Philip D. Davies, Corporate VP of Global Sales and Marketing and a director at Vicor Corporation, filed a Form 4 on September 3, 2026, reporting the exercise of stock options and the sale of common stock on September 1, 2026, under a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Option exercise: Davies exercised a Non-Qualified Stock Option for 3,073 shares of Common Stock at an exercise price of $41.61 per share on September 1, 2026.
  • Total shares sold: Davies disposed of 3,073 shares across four separate sale transactions, all on September 1, 2026.
  • Sale prices: The four tranches were sold at weighted average prices of $176.5922, $177.6312, $178.66, and $184.85 per share, respectively.
  • Remaining ownership: Following all reported transactions, Davies directly held 1,920 shares of Common Stock and 856 Non-Qualified Stock Options.
  • 10b5-1 plan: According to the filing, all sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Davies on November 21, 2025.
  • Issuer: Vicor Corporation, trading on NASDAQ:VICR.

Davies Option Exercise and Planned Share Sales at Vicor Corporation

According to the filing, Philip D. Davies, who serves as both a director and Corporate VP of Global Sales and Marketing at Vicor Corporation (NASDAQ:VICR), exercised a Non-Qualified Stock Option covering 3,073 shares of Common Stock on September 1, 2026. The exercise price was $41.61 per share. Prior to the exercise and subsequent sales, Davies held 4,993 shares of Common Stock directly, the filing reported.

The filing disclosed four separate sale transactions, all executed on September 1, 2026, under transaction code "S." A total of 1,173 shares were sold at a weighted average price of $176.5922, with individual transaction prices ranging from $176.0000 to $176.9900. An additional 1,100 shares were sold at a weighted average of $177.6312, with prices ranging from $177.3000 to $177.8800. A further 700 shares were sold at a weighted average of $178.66, with prices ranging from $178.4300 to $179.0400. Finally, 100 shares were sold at $184.85, with prices ranging from $184.8500 to $184.8500. The filing noted that Davies undertakes to provide full information on shares sold at each separate price upon request to Vicor Corporation, any security holder, or SEC staff.

All four sales were reported as effected pursuant to a Rule 10b5-1 trading plan that Davies adopted on November 21, 2025, according to the filing. The Form 4 was signed by Quentin A. Fendelet as Attorney in Fact for Philip D. Davies and filed on September 3, 2026. The filing indicated the box for a Rule 10b5-1(c) plan was checked.

What Was Disclosed

The filing reported that Davies exercised 3,073 options at $41.61 per share and sold 3,073 shares of Vicor Common Stock in four tranches on September 1, 2026, under a pre-adopted Rule 10b5-1 plan, leaving him with 1,920 directly held shares.